Publications by authors named "Y O Korsakova"
Article Synopsis
- - The study aimed to investigate the frequency and risk factors for diastolic dysfunction (DD) in patients with calcium pyrophosphate crystal deposition disease (CPPD) and osteoarthritis (OA), finding a high prevalence of DD among participants.
- - Among 26 patients without cardiovascular diseases, DD was detected in 19 individuals, with similar rates of type 1 LV and RV DD in both CPPD and OA groups, while types 2 and 3 DD were not present.
- - Significant differences in certain cardiac indices were observed between the two groups, with higher levels of inflammation (CRP) noted in CPPD patients, highlighting complex relationships between diastolic function and various health factors in CPPD and OA. *
The objective of the study was to analyze whether axial psoriatic arthritis (axPsA) patients meet classification criteria for axial spondyloarthritis (axSpA) and ankylosing spondylitis (AS). A total of 104 patients (66 men and 38 women) with PsA according to CASPAR criteria were examined, all patients had back pain. Patients were evaluated for presence of inflammatory back pain (IBP) by ASAS criteria.
View Article and Find Full Text PDFAim: To study and compare the clinical and imaging characteristics of psoriatic arthritis (PsA) in men and women.
Materials And Methods: The study included 956 PsA patients observed in the Russian register, 411 (43%) men and 545 (57%) women. The average age of men/women was 46.
Aim: To develop an integral index of psoriatic arthritis (PsA) activity.
Materials And Methods: 117 patients with PsA (M/F - 63/54) were included. Patients' age 44±11 years, psoriasis (Ps) duration - 213±153 months, PsA duration - 73.
Background: Calcium pyrophosphate crystal deposition disease (CPPD) may be associated with developing of diastolic dysfunction (DD).
Aim: To determine the variability of echocardiographic parameters in patients with CPPD receiving anti-inflammatory therapy.
Materials And Methods: Twenty six patients with CPPD and osteoarthritis (OA) from 18 to 65 years old were included in the case-control study.